Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Cell Reports|January 25, 2026
Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASHKenneth Li, Vardhman Kumar, Tran To, et al.
Hepatology (Baltimore, Md.)|July 29, 2014
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological responseKian Bichoupan, Valerie Martel-Laferriere, David Sachs, et al.
World Journal of Hepatology|May 5, 2017
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infectionKian Bichoupan, Neeta Tandon, Valerie Martel-Laferriere, et al.
World Journal of Virology|November 18, 2017
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial resultsKian Bichoupan, Neeta Tandon, James F Crismale, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis CMaria Buti, Joost P H Drenth, Manuel Mendizabal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 20, 2020
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center StudyDonghee Kim, Nia Adeniji, Nyann Latt, et al.
American Journal of Preventive Cardiology|June 15, 2026
AI-CVD-HF: A heart failure risk prediction model based on coronary artery calcium scans compared with PREVENT-HFSeyed Reza Mirjalili, Kyle Atlas, Anthony P Reeves, et al.
European Heart Journal. Cardiovascular Imaging|January 27, 2026
AI-CVD-AF: A Novel Atrial Fibrillation Prediction Model Based on Coronary Artery Calcium ScansSeyed Reza Mirjalili, Kyle Atlas, Anthony P Reeves, et al.
Pageof 10